Fingerprint
Dive into the research topics of 'First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically